- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Cleveland Clinic Reaches Milestones in Heart Transplantation and Lung Transplantation
In July, Cleveland Clinic completed their 2000th heart and 2000th lung transplantations as the third program in the country to reach this landmark
In July, Cleveland Clinic completed their 2000th heart and 2000th lung transplantations as the third program in the country to reach this landmark. Cleveland Clinic is one of the largest heart transplant programs in the country with survival outcomes higher than the national average. (SRTR Data: Adult 1 yr survival: 97% {national avg 91%} and 3 yr survival: 88% {national avg 85%} Peds: 3 yr survival: 95% {national avg 89%})
Cleveland Clinic began innovative work on heart transplants in 1968, with the official beginning of the program in 1984. On average, Cleveland Clinic performs 50 to 60 transplants per year, including between 5 to 8 pediatric transplants per year. In 1998, a record-breaking year for the program, 113 patients were transplanted, including 8 pediatric patients.
Building Accountability Into GLP-1 Benefit Design: Lessons From Delaware and Philadelphia
August 20th 2025Employers explore glucagon-like peptide-1 (GLP-1) therapies' impact on health benefits, showcasing accountability and data-driven strategies in Philadelphia, Pennsylvania, and Wilmington, Delaware, for sustainable health programs.
Read More
GLP-1 Receptor Agonists Reduce Adverse Cardiovascular Outcomes, Improve Survival
August 2nd 2025Studies found that glucagon-like peptide-1 (GLP-1) receptor agonists were valuable tools in improving outcomes and survival in those with coronary plaque and after ST-elevation myocardial infarction.
Read More
